REGENERON PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
REGENERON PHARMACEUTICALS, INC. (REGN) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $43.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-04
- REGENERON PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $43.10M.
- REGENERON PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $5.00M.
- REGENERON PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $7.20M.
- REGENERON PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2017 was $5.60M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $43.10M 10-K · filed 2026-02-04 |
| 2022-12-31 | $5.00M 10-K · filed 2025-02-05 |
| 2019-12-31 | $7.20M 10-K · filed 2022-02-07 |
| 2017-12-31 | $5.60M 10-K · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |